Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

NetScientific researcher wins top US award

Professor Dino Di Carlo received the award for devising a ‘liquid biopsy’ technique

The founder and chief scientific advisor of NetScientific (LON:NSCI) subsidiary Vortex Biosciences has been awarded the US’s highest award for accomplishments in science and engineering.

Professor Dino Di Carlo received the Presidential award for devising a first-of-its-kind technique to quickly separate rare and information-rich circulating tumour cells from common blood cells.

Vortex was set up in 2012 to commercialise this ‘liquid biopsy’ technique for in applications such as diagnosis, treatment selection and monitoring, compound discovery and next generation sequencing.

Francois Martelet, NetScientific’s chief executive, said: “Vortex is our lead diagnostics company and we are delighted for Dino Di Carlo to have received this outstanding recognition for his work.

“This further endorses Vortex's core technology as we continue to accelerate its development towards a potential best-in-class technology."

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK